[Experiences with depot-neuroleptics in an after-care unit. Organization of the therapy exemplified with pipotiazine palmitate].
D000293:Adolescent; D000328:Adult; D000368:Aged; D014150:Antipsychotic Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D010169:Palmitic Acids / Q000008:administration & dosage; D010259:Paranoid Disorders / Q000188:drug therapy*; D010640:Phenothiazines; D010880:Piperidines / Q000008:administration & dosage / Q000627:therapeutic use; D011604:Psychoses, Alcoholic / Q000188:drug therapy*; D012559:Schizophrenia / Q000188:drug therapy*; D013449:Sulfonamides / Q000008:administration & dosage
D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D010169:Palmitic Acids; D010640:Phenothiazines; D010880:Piperidines; D013449:Sulfonamides
Erfaringer med depot-neuroleptika i ettervern. Organisering og resultater av behandlingen belyst ved bruk av pipotiazin palmitat.